CELL U RITE NATURALS Trademark

Trademark Overview


On Wednesday, November 16, 2011, a trademark application was filed for CELL U RITE NATURALS with the United States Patent and Trademark Office. The USPTO has given the CELL U RITE NATURALS trademark a serial number of 85474481. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 14, 2020. The CELL U RITE NATURALS trademark is filed in the Pharmaceutical Products category with the following description:

Goods containing or prepared from natural ingredients, namely, meal replacement powders, meal replacement bars, nutritional supplement energy bars, dietary fiber as a food additive, protein supplement shakes, meal replacement drinks, vitamin enhanced water, electrolyte drinks for medical purposes to treat dehydration, dietary supplements for promoting weight loss, herbal supplements for the promotion of healthy liver function, herbal supplements for the treatment of arthritis, herbal supplements for the treatment of cardiovascular disease, herbal supplements for the treatment of dental and oral diseases, herbal supplements for the treatment of headaches, herbal supplements for the treatment of cold and flu, herbal supplements for treating urinary tract infections, herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, herbal supplements for the treatment of the musculoskeletal system, namely, conne...
cell u rite naturals

General Information


Serial Number85474481
Word MarkCELL U RITE NATURALS
Filing DateWednesday, November 16, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 14, 2020
Registration Number4460807
Registration DateTuesday, January 7, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2013

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"NATURALS"
Description of MarkThe mark consists of the stylized wording "CELL U RITE NATURALS" and a design comprised of a first leaf to the left of a second leaf, with the leaves situated above the center of an oblong that is divided in the middle by a curved separation, with the curved line formed by the separation of the sides of the oblong appearing to meet with the leaves in a manner suggesting that the leaves are on a stem, with the wording "CELL U RITE" appearing across the oblong design and the word "NATURALS" appearing beneath the oblong design.
Goods and ServicesGoods containing or prepared from natural ingredients, namely, meal replacement powders, meal replacement bars, nutritional supplement energy bars, dietary fiber as a food additive, protein supplement shakes, meal replacement drinks, vitamin enhanced water, electrolyte drinks for medical purposes to treat dehydration, dietary supplements for promoting weight loss, herbal supplements for the promotion of healthy liver function, herbal supplements for the treatment of arthritis, herbal supplements for the treatment of cardiovascular disease, herbal supplements for the treatment of dental and oral diseases, herbal supplements for the treatment of headaches, herbal supplements for the treatment of cold and flu, herbal supplements for treating urinary tract infections, herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries, herbal supplements for the treatment of asthma, sinusitis, herbal supplements for use in dermatology, namely, acne, dermatitis, eczema, psoriasis, dietary supplement to treat digestive system discomforts, namely, blood sugar regulation, acid reflux, irritable bowel syndrome, herbal supplements to treat female hormonal imbalance, herbal supplements to treat mood disorders, edible fish oils for medical purposes, dietary and nutritional supplements containing omega fatty acids, mineral supplements, nutritional supplements for building body mass, dietary and food supplements containing whey, soy, rice, pea, and/or canola, vitamin supplements, dietary and herbal supplements to enhance energy and performance, medicated skin care preparations, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of acne, pharmaceutical preparations for the treatment of allergies, pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for the treatment of carpal tunnel syndrome, pharmaceutical preparations for the treatment of chronic pain, pharmaceutical preparations for the treatment of dental and oral diseases, pharmaceutical preparations for the treatment of diabetes, pharmaceutical preparations for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, pharmaceutical preparations for the treatment of glaucoma, pharmaceutical preparations for the treatment of headaches, pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, pharmaceutical preparations for the treatment of migraine, pharmaceutical preparations for the treatment of motion sickness, pharmaceutical preparations for the treatment of myalgia and neuralgia, pharmaceutical preparations for the treatment of neurological diseases, namely, preparations for treatment of Alzheimer's disease, Huntington's disease and cerebral palsy, pharmaceutical preparations for the treatment of ophthalmological diseases and disorders, pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, internet addiction, drug addiction, pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, seizures, pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections, pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne, pharmaceutical preparations for the treatment of smoking cessation, pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, pharmaceutical preparations for the treatment of the respiratory system, pharmaceutical preparations for the treatment of varicose veins, pharmaceutical preparations for the treatment of vascular diseases, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids), pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, pharmaceutical preparations for use in gastroenterology, pharmaceutical preparations for use in ocular disorders, pharmaceutical preparations for use in oncology, pharmaceutical preparations for use in ophthalmology, radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use
Pseudo MarkCELL YOU RITE NATURALS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressMinesing, Ontario L0L1Y3
CA

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMinesing, Ontario L0L1Y3
CA

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMinesing, Ontario L0L1Y3
CA

Trademark Events


Event DateEvent Description
Friday, August 14, 2020CANCELLED SEC. 8 (6-YR)
Monday, January 7, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 8, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 7, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, November 27, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, October 22, 2013NOTICE OF ALLOWANCE CANCELLED
Wednesday, November 27, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 22, 2013TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 22, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 19, 2013EXAMINER'S AMENDMENT ENTERED
Friday, July 19, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2013EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, July 18, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 18, 2013NON-FINAL ACTION E-MAILED
Thursday, July 18, 2013NON-FINAL ACTION WRITTEN
Thursday, July 11, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, June 28, 2013WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, June 19, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 17, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 30, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 21, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2013NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2013NON-FINAL ACTION WRITTEN
Tuesday, April 30, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 23, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 29, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 29, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, January 29, 2013SUSPENSION LETTER WRITTEN
Tuesday, January 29, 2013ASSIGNED TO EXAMINER
Tuesday, January 8, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 8, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 2, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 2, 2013INQUIRY TO SUSPENSION E-MAILED
Wednesday, January 2, 2013SUSPENSION INQUIRY WRITTEN
Thursday, December 6, 2012LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, June 1, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 1, 2012LETTER OF SUSPENSION E-MAILED
Friday, June 1, 2012SUSPENSION LETTER WRITTEN
Thursday, May 10, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 10, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 3, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2012NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2012NON-FINAL ACTION WRITTEN
Friday, March 2, 2012ASSIGNED TO EXAMINER
Monday, February 27, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2012ASSIGNED TO LIE
Tuesday, February 7, 2012TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 23, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, November 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 19, 2011NEW APPLICATION ENTERED IN TRAM